ZymoGenetics Inc.
Records under this name other than the patents ZymoGenetics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 57 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,062,876 | Method for Activating PRETHROMBIN-1 now held by Baxter International, Inc. In force · High confidence | In force | High confidence | |
| US 9,597,062 | Medical Devices for Delivering Fluids During Surgery and Methods for Their Use now held by Baxter International, Inc. In force · High confidence | In force | High confidence | |
| US 9,629,798 | Hemostatic Microspheres now held by Baxter International, Inc. In force · High confidence | In force | High confidence | |
| US 8,071,090 | Stabilized Thrombin Compositions now held by Baxter International, Inc. In force · High confidence | In force | High confidence | |
| US 8,759,066 | Thrombin Activator Compositions and Methods of Making and Using the Same now held by Baxter International, Inc. In force · High confidence | In force | High confidence | |
| US 9,156,909 | Polynucleotides Encoding IL-31 Monoclonal Antibodies Term ended Term ended Oct 22, 2026 · Medium confidence | Term ended | Term ended Oct 22, 2026 | Medium confidence |
| US 9,624,296 | Polynucleotides Encoding IL-31 Monoclonal Antibodies Term ended Term ended Oct 22, 2026 · High confidence | Term ended | Term ended Oct 22, 2026 | High confidence |
| US 7,537,761 | ANTI-IL-22RA Antibodies and Binding Partners and Methods of Using in Inflammation Term ended Term ended Oct 17, 2026 · High confidence | Term ended | Term ended Oct 17, 2026 | High confidence |
| US 8,759,027 | Production and Purification of IL-29 Term ended Ended no later than Oct 4, 2026 · Low confidence | Term ended | Ended no later than Oct 4, 2026 | Low confidence |
| US 8,926,957 | Methods of Using IL-31 Antagonists in Diseases Mediated by Cutaneous Lymphocyte Antigen Positive T Cells Term ended Term ended Jun 16, 2026 · Medium confidence | Term ended | Term ended Jun 16, 2026 | Medium confidence |